Charles River Laboratories | Ativo Circulante





Ativo Circulante Alterar Data
Agilent USD 4.59B 341M 2025-09
Align Technology USD 2.62B 82.47M 2025-12
Bio-Rad Laboratories USD 2.91B 64.2M 2025-12
Bruker USD 2.21B 138.1M 2025-12
Cardinal Health USD 39.23B 693M 2025-12
Charles River Laboratories USD 1.45B 85.06M 2025-12
Cigna USD 46.74B 2.01B 2025-09
Concord Medical Services Hldg CNY 850.84M 91.04M 2023-06
CVS Health USD 74.71B 2.4B 2025-12
Danaher USD 12.76B 3.15B 2025-12
Dentsply International USD 2.07B 106M 2025-09
Elevance Health USD 63B 777M 2025-12
Galapagos EUR 3.16B 93.29M 2025-09
Hologic USD 3.84B 175.3M 2025-12
Humana USD 32.73B 19M 2025-12
Illumina USD 3.29B 493M 2025-12
Incyte USD 5.02B 746.01M 2025-12
Intrexon USD 23.72M 45.04M 2024-06
IQVIA Holdings USD 6.25B 270M 2025-12
Laboratory Of America USD 4.02B 58.3M 2025-12
Lonza CHF 5.44B 113M 2024-12
McKesson USD 59.7B 190M 2025-12
Merck EUR 12.88B 680M 2025-09
Mettler Toledo International USD 1.36B 81.46M 2025-12
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Quest Diagnostics USD 2.38B 29M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Thermo Fisher Scientific USD 28.71B 6.41B 2025-12
United Therapeutics USD 3.49B 332.9M 2025-09
UnitedHealth USD 95.07B 1.37B 2025-09
Veradigm USD 810.77M 18M 2022-09
Waters USD 1.99B 69.86M 2025-12
West Pharmaceutical Services USD 1.98B 154.9M 2025-12


Charles River Laboratories Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.